Usage of nanocrystalline cellulose phosphate as novel sustained release system for anti-inflammatory drugs

1,2,3-Triazole-based esters and carboxylic acids as nonclassical carbonic anhydrase inhibitors capable of cathepsin B inhibition

Herein, we report the design and synthesis of a library of 28 new 1,2,3-triazole derivatives bearing carboxylic acid and ester moieties as dual inhibitors of carbonic anhydrase (CA) and cathepsin B enzymes. The synthesised compounds were assayed in vitro for their inhibition potential against four human CA (hCA) isoforms, I, II, IX and XII. The carboxylic acid derivatives displayed low micromolar inhibition against hCA II, IX and XII in contrast to the ester derivatives. Most of the target compounds showed poor inhibition against the hCA I isoform. 4-Fluorophenyl appended carboxylic acid derivative 6c was found to be the most potent inhibitor of hCA IX and hCA XII with a KI value of 0.7 μM for both the isoforms. The newly synthesised compounds showed dual inhibition towards CA as well as cathepsin B. The ester derivatives exhibited higher % inhibition at 10-7  M concentration as compared with the corresponding carboxylic acid derivatives against cathepsin B. The results from in silico studies of the target compounds with the active site of cathepsin B were found in good correlation with the in vitro results. Moreover, two compounds, 5i and 6c, showed cytotoxic activity against A549 lung cancer cells, with IC50 values lower than 100 μM.

Keto-bridged dual triazole-linked benzenesulfonamides as potent carbonic anhydrase and cathepsin B inhibitors

Background: Inhibition of human carbonic anhydrase (hCA) isoforms IX and XII with concurrent inhibition of cathepsin B is a promising approach for targeting cancers. Methods/results: 28 keto-bridged dual triazole-containing benzenesulfonamides were synthesized and tested, following the multitarget approach, for their efficacy as inhibitors of cathepsin B and hCA isoforms (I, II, IX, XII). The synthesized compounds showed excellent inhibition of CA isoforms (IX and XII) and cathepsin B. Compound 8i exhibited better and more selective inhibition of the cancer-associated isoform hCA IX as compared with acetazolamide (reference drug) and SLC-0111 (potent lead as carbonic anhydrase inhibitor). Molecular docking studies were also carried out. Conclusion: The present work gives important generalizations for the development of isoform-selective hCA inhibitors endowed with anti-cathepsin properties.

Recent advances in cellulose, pectin, carrageenan and alginate-based oral drug delivery systems

Polymers-based drug delivery systems constitute one of the highly explored thrust areas in the field of the medicinal and pharmaceutical industries. In the past years, the properties of polymers have been modified in context to their solubility, release kinetics, targeted action site, absorption, and therapeutic efficacy. Despite the availability of diverse synthetic polymers for the bioavailability enhancement of drugs, the use of natural polymers is still highly recommended due to their easy availability, accessibility, and non-toxicity. The aim of the review is to provide the available literature of the last five years on oral drug delivery systems based on four natural polymers i.e., cellulose, pectin, carrageenan, and alginate in a concise and tabulated manner. In this review, most of the information is in tabulated form to provide easy accessibility to the reader. The data related to active pharmaceutical ingredients and supported components in different formulations of the mentioned polymers have been made available.

Design and development of carboxymethylcellulose ester of curcumin as sustained release delivery system in liver

In the present work chemical transformation of carboxymethylcellulose with curcumin in ester form has led to the development of target specific sustained release delivery system for curcumin in presence of liver esterases. We here report synthesis, characterizations (FTIR, SEM and XRD) curcumin-carboxymethylcellulose ester (Cur-CMC ester) and its target specific hydrolysis to release curcumin. Cur-CMC ester has been found stable when simulated in-vitro in gastric fluid (pH 1.2) and in intestinal fluid (pH 6.8). On in-vitro simulation in liver homogenate curcumin is released from Cur-CMC ester after hydrolysis in a consistent amount (∼43 %) for 5 h. The release of curcumin from ester was highest at pH 8.0 in presence of liver enzymes. The present study suggested that modified CMC support can not only be used for the delivery of curcumin in liver but also acts as prodrug system and released free curcumin in presence of liver esterases.

Syntheses, Structural and Serum Protein Protecting Activity of Ruthenium(II)-DMSO Complexes Containing Mercapto Ligand

Four new ruthenium(II) complexes [Ru(mpt)2(DMSO)2] (1), [Ru(mpt)2(bpy)] (2), [Ru(mpt)2(phen)] (3) and [Ru(mpt)2(tptz)] (4) have been synthesized and characterized by elemental analyses, IR, 1H and 13C NMR, and electronic absorption spectroscopy....

A critical review on the techniques used for the synthesis and applications of crystalline cellulose derived from agricultural wastes and forest residues

In order to meet the growing energy crisis of the 21st century, the utilization of bio-based materials has become a field of high research endeavour. In view of that, the present review paper is focused on different techniques that are frequently explored for the synthesis of value-added crystalline derivatives of cellulose like MCC and NCC from agricultural wastes and forest residues. Moreover, a comparative analysis between thermochemical and biochemical methods is carried out for such valorization of biomass considering the mechanism involved with various reactions. Further, a critical analysis is performed on various individual techniques specifically used for the applications of MCC and NCC in different fields including environmental, polymer industry, pharmaceutical and other emerging sectors. This article will assist the readers not only to explore new biomass sources but also provides an in-depth insight on various green and cost-effective methods for sustainable production of crystalline cellulose.

Nanocelluloses: Sources, Pretreatment, Isolations, Modification, and Its Application as the Drug Carriers

The 'Back-to-nature' concept has currently been adopted intensively in various industries, especially the pharmaceutical industry. In the past few decades, the overuse of synthetic chemicals has caused severe damage to the environment and ecosystem. One class of natural materials developed to substitute artificial chemicals in the pharmaceutical industries is the natural polymers, including cellulose and its derivatives. The development of nanocelluloses as nanocarriers in drug delivery systems has reached an advanced stage. Cellulose nanofiber (CNF), nanocrystal cellulose (NCC), and bacterial nanocellulose (BC) are the most common nanocellulose used as nanocarriers in drug delivery systems. Modification and functionalization using various processes and chemicals have been carried out to increase the adsorption and drug delivery performance of nanocellulose. Nanocellulose may be attached to the drug by physical interaction or chemical functionalization for covalent drug binding. Current development of nanocarrier formulations such as surfactant nanocellulose, ultra-lightweight porous materials, hydrogel, polyelectrolytes, and inorganic hybridizations has advanced to enable the construction of stimuli-responsive and specific recognition characteristics. Thus, an opportunity has emerged to develop a new generation of nanocellulose-based carriers that can modulate the drug conveyance for diverse drug characteristics. This review provides insights into selecting appropriate nanocellulose-based hybrid materials and the available modification routes to achieve satisfactory carrier performance and briefly discusses the essential criteria to achieve high-quality nanocellulose.

Cashew Gum Polysaccharide Nanoparticles Grafted with Polypropylene Glycol as Carriers for Diclofenac Sodium

This investigation focuses on the development and optimization of cashew gum polysaccharide (CGP) nanoparticles grafted with polypropylene glycol (PPG) as carriers for diclofenac sodium. The optimization of parameters affecting nanoparticles formulation was performed using a central composite rotatable design (CCRD). It was demonstrated that the best formulation was achieved when 10 mg of CGP was mixed with 10 μL of PPG and homogenized at 22,000 rpm for 15 min. The physicochemical characterization evidenced that diclofenac was efficiently entrapped, as increases in the thermal stability of the drug were observed. The CGP-PPG@diclofenac nanoparticles showed a globular shape, with smooth surfaces, a hydrodynamic diameter around 275 nm, a polydispersity index (PDI) of 0.342, and a zeta potential of -5.98 mV. The kinetic studies evidenced that diclofenac release followed an anomalous transport mechanism, with a sustained release up to 68 h. These results indicated that CGP-PPG nanoparticles are an effective material for the loading/release of drugs with similar structures to diclofenac sodium.